All Rights reserved

Health and Family

Prevention is better than cure



First Artificail Pancreas

MiniMed670G device which moniter glucose level every 5 minutes and releases insulin as per the requirment continiously is approved by the FDA USA for use in general public.


WHO report warns global actions and investments to end tuberculosis epidemic are falling far short

  New data published by WHO in its 2016   "Global Tuberculosis Report"   show that countries need to move much faster to prevent, detect, and treat the disease if they are to meet global targets.

Governments have agreed on targets to end the tuberculosis (TB) epidemic both at the World Health Assembly and at the United Nations General Assembly within the context of the Sustainable Development Goals. They include a 90% reduction in TB deaths and an 80% reduction in TB cases by 2030 compared with 2015.

"We face an uphill battle to reach the global targets for tuberculosis," said Dr Margaret Chan, WHO Director General. "There must be a massive scale-up of efforts, or countries will continue to run behind this deadly epidemic and these ambitious goals will be missed."

The WHO 2016   "Global Tuberculosis Report"   highlights the considerable inequalities among countries in enabling people with TB to access existing cost-effective diagnosis and treatment interventions that can accelerate the rate of decline in TB worldwide. The report also signals the need for bold political commitment and increased funding.


Is the law to improve public health can bring change in our living?

Soda tax in Mexico. Salt limits in South Africa. Plain tobacco packaging in Australia. National health insurance in Ghana. A new report produced by WHO and partners has case studies on how new laws have improved the health and safety of people, providing a resource for countries to learn from positive experiences in other parts of the world.  

                                                      CLICK HERE


Leprosy Day

Scale up efforts against leprosy; focus on preventing disabilities in children

Enhanced efforts, renewed commitment, and an inclusive approach is needed to end the scourge of leprosy which continues to afflict thousands of people every year, the majority of them in the WHO South-East Asia Region.

Leprosy affected 212 000 more people globally in 2015. Of them 60% were in India. The other high-burden countries were Brazil and Indonesia. Of the new cases 8.9% were children and 6.7% presented with visible deformities.

Despite being eliminated globally as a public health problem in 2000, leprosy continues to mar the lives of individuals, and impacts families and communities. Though present numbers are a fraction of what was reported a decade ago, they are unacceptable, as an effective treatment for leprosy - multidrug therapy, or MDT – has been available since the 1980s and can fully cure leprosy.

World Leprosy Day, observed on the last Sunday of January, focuses on the target of zero cases of leprosy-related disabilities in children. Disabilities do not occur overnight, but happen after a prolonged period of undiagnosed disease. Early detection is key to achieve this target, alongside scaling up interventions to prevent leprosy transmission.

Addressing the socio-economic needs of affected persons and communities and taking concrete measures to end stigma – often the reason for late diagnosis – is vitally important.

To effectively combat stigma, a multisectoral approach is needed. Health authorities need to reach out to and include leprosy-affected persons and communities in their programming. Laws or regulations that sanction or abet discrimination against persons suffering leprosy should be repealed. A concert of voices should be mobilized to counter harmful social attitudes. Nongovernmental and civil society organizations should be included in campaigns to challenge leprosy-related stigma, and to address discrimination against affected persons and their family members.

As long as leprosy transmission and associated disabilities exist, so will stigma and discrimination and vice-versa.

The World Leprosy Day is an opportunity for renewed commitment to rid humanity of the debilitating disease at the earliest.

2018 annual review of the Blueprint list of priority diseases

For the purposes of the R&D Blueprint, WHO has developed a special tool for determining which diseases and pathogens to prioritize for research and development in public health emergency contexts. This tool seeks to identify those diseases that pose a public health risk because of their epidemic potential and for which there are no, or insufficient, countermeasures. The diseases identified through this process are the focus of the work of R& D Blueprint. This is not an exhaustive list, nor does it indicate the most likely causes of the next epidemic.    CLICK HERE